Skip to content

Zymeworks ZYME Change in Other Assets

Change in Other Assets at other companies

Pfizer logo
PfizerPFE
-$322.25M+61.9%
Amgen logo
AmgenAMGN
-$8M-104%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$1.5M-183%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.33M+919%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.74M+124%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.59M+192%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's change in other assets?
Zymeworks (ZYME) reported change in other assets of $1.73M in Q1 2026.
How has Zymeworks's change in other assets changed year-over-year?
Zymeworks's change in other assets increased by 160.1% year-over-year, from -$2.87M to $1.73M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.